Abstract
This paper is aimed at providing practical recommendations for the management of acute hepatitis C (AHC). This is an expert position paper based on the literature revision. Final recommendations were graded by level of evidence and strength of the recommendations. Treatment of AHC with direct-acting antivirals (DAA) is safe and effective; it overcomes the limitations of INF-based treatments. Early treatment with DAA should be offered when available.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
